Zdrowie i gospodarka · 14/07/2016

FDA Clears PARAFON FORTE DSC Tablets for Sale, Citing Lack of Safety or Effectiveness Concerns

The US Food and Drug Administration (FDA) has ruled that PARAFON FORTE DSC (chlorzoxazone) tablets, 500mg, were not withdrawn from the market due to safety or efficacy concerns, allowing the agency to approve abbreviated new drug applications (ANDAs) for this product if all regulatory requirements are met.